Bicycle Therapeutics Plc
Company Overview
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company developing innovative medicines based on its proprietary bicyclic peptide (Bicycle®) technology. The company focuses on developing treatments for cancer and other diseases. Their technology platform enables them to rapidly screen and identify drug candidates that could potentially treat various diseases.
The company's lead programs include BT8009, BT5528, and BT7480, which are being developed for various types of cancers. These candidates are currently in different phases of clinical trials.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $2.68m | $67.51m | - | $987000.0 | 0.00% | 1.46% |
| June 30, 2024 | $9.36m | $56.83m | - | $824000.0 | 0.00% | 1.45% |
| March 31, 2024 | $19.53m | $52.07m | - | $821000.0 | 0.00% | 1.58% |
Company Impact
Help us evaluate Bicycle Therapeutics Plc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.